free social media buttons

Inclined Bed Therapy

Inclined Bed Therapy (IBT)

Sleeping Inclined To Restore and Support Your Health For Free. Fascinating Science, Discovery, History and Medical Research In Circulation And Posture, by Andrew K Fletcher

 

Latest From The Forum

    • file
    • Eye irrigation removes cataracts safely using deionised / distilled water
    • Hi Andrew, How interesting! I have only in the last week been diagnosed with cataracts (I am 59) which I have been told are minor and described as 5%. I personally think that my worsening distance vision and now cataracts haven't been helped by having Intensive Hyperbaric Oxygen treatment recently, I believe that eyesight can take a while to settle, from weeks to months in fact so I intend to check my prescription once more in 6 months. The reason for telling you this is that after too long a gap because of certain life events, not least of which was my husband being diagnosed with Lymphoma which he is now thankfully in remission from, I am now returning to IBT. I began with IBT roughly 6 years ago and submitted a tracking report to you at the time (I have MS) I was wondering about this thread, if you are meaning that IBT alongside the ionised water is making the difference with cataracts or just the eye washing alone? Can't promise to manage 4 eye washes a day, although we have bought the ionised water today in readiness and willing to try at least once a day! What we WILL be doing is sleeping inclined again starting last week and I would be more than willing to let you know in 6 months if there has been a change in my cataracts percentage wise if it might be helpful? Hope I manage to post this as I’m a bit of a technophobe! Thanking you for all the care and attention you give in getting your message across re IBT. Best wishes Elaine.
    • In IBT Forum / General discussion
    • Author Elaine
    • 3 days 12 hours ago

THE LANCET
42 Bedford Square London WC1B SSL United Kingdom
TEL  +44(0)171 4364981 FAX +44 (0)171 436 7570
JB/HEG                                    Please quote ref:
17 September 1997
Mr Andrew Fletcher
The Multiple Sclerosis Resource Centre
4a Chapel Hill
Stanstead
ESSEX CM24 SAG


Dear Mr Fletcher,
I am pleased to see that some of the patients treated improved.
For our purposes, however, this account cannot be accepted as proof of efficacy. Testing new treatments in MS is a very difficult business because of the day-to-day variability of the disease.
With best wishes. Yours sincerely,
John Bignall MB Senior Editor


U.S. Agent for The Lancet, 655 Avenue of the Americas, New York, NY 10010
The Lancet Limited, 42 Bedford Square, London WC1B 3SL, U.K. Registered in England. Company number 1016593 England.

 

Please support Andrew's research

Amount: